Leading U.S. Pediatricians' Group Reaffirms Support for Gender-Related Care for Minors
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
FRIDAY, Aug. 4, 2023 -- A leading U.S. pediatric organization has reaffirmed its support for gender-related treatments in minors, but also plans a systematic review of the medical research.
The move by the American Academy of Pediatrics (AAP) to examine research on the treatments is similar to recent moves in England and Sweden. Both limited access to the treatments after their reviews found uncertain evidence for their effectiveness in adolescents, the New York Times reported.
“The board has confidence that the existing evidence is such that the current policy is appropriate,” said Mark Del Monte, chief executive of the AAP, which represents 67,000 pediatricians. “At the same time, the board recognized that additional detail would be helpful here.”
Asked about the policy changes in European countries, Del Monte said, “they engaged in their process, we’re engaging in our process.”
A systematic review of the evidence is considered the gold standard.
The AAP issued a statement on gender-related treatments in 2018, and it's customary for the group to reevaluate position statements after five years, the Times reported.
The 2018 statement said the treatments were essential and should be covered by health insurers. The group's 16-member board reaffirmed the guidelines Thursday.
After the new review is complete, the organization plans to issue additional clinical guidance for doctors. It is also likely to update its recommendations at that time.
As in Europe, gender-affirming care for minors is at the center of political debate in the United States. Opponents consider it experimental. Republican lawmakers have banned it in 19 states.
This care can include psychotherapy, puberty-blocking drugs, hormones and, rarely, surgeries. Early evidence suggested that gender-affirming care could improve the mental health of transgender adolescents.
The AAP says legislative bans intrude on decisions by doctors and their patients. The academy has filed friend-of-the-court briefs in support of court challenges to these bans, the Times reported.
Dr. Julia Mason, an Oregon pediatrician who co-founded a group called the Society for Evidence-Based Gender Medicine, told the Times she was glad to see that a review is planned.
“We are making strong recommendations based on weak evidence,” she said.
Dr. Marci Bowers, a gynecologic and reconstructive surgeon and the president of the World Professional Association for Transgender Health, said gender-related care profoundly improves many children’s lives.
“They know this population,” said Bowers, who is a transgender woman. “They know the stories. Anecdotally, it’s overwhelmingly positive.”
Referring to policies abroad, she noted that Europe has not banned gender-related care entirely.
“What they’re saying is this population needs to be studied,” she said. “And I agree with that.”
The European changes include a decision in June by England’s National Health Service to restrict the use of puberty blockers to clinical trials. The NHS said “there is not enough evidence to support their safety or clinical effectiveness as a routinely available treatment.”
Last year, Sweden’s health care governing body decided the risks of puberty-inhibiting and gender-affirming hormone treatments outweigh the benefits for those under 18.
Sources
- New York Times
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Stress, Discrimination Add to Cancer Burden for LGBTQ+ Americans
FRIDAY, May 31, 2024 -- While LGBTQ+ people have higher risk factors for cancer, they are apt to face discrimination when in need of high-quality medical care, a new report...
Lesbian, Bisexual Women More Likely to Die Early Than Straight Peers
MONDAY, May 13, 2024 (HealthDay news) -- Could being a lesbian or bisexual shorten your life? New research that analyzed decades of data on women suggests it might. What's...
1 in 3 Trans Masculine People Taking Testosterone Can Still Ovulate: Study
FRIDAY, Feb. 23, 2024 -- A third of trans masculine people who have undergone testosterone therapy and have stopped menstruating are still ovulating, a new study suggests. That...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
